Raymond James & Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,990
Closed -$1.32M 4109
2021
Q2
$1.32M Sell
7,990
-293
-4% -$48.4K ﹤0.01% 2396
2021
Q1
$1.27M Sell
8,283
-455
-5% -$69.8K ﹤0.01% 2334
2020
Q4
$1.1M Sell
8,738
-86
-1% -$10.8K ﹤0.01% 2275
2020
Q3
$895K Buy
8,824
+721
+9% +$73.1K ﹤0.01% 2235
2020
Q2
$788K Sell
8,103
-4,201
-34% -$409K ﹤0.01% 2311
2020
Q1
$1.02M Buy
12,304
+1,014
+9% +$84.2K ﹤0.01% 1960
2019
Q4
$1.26M Sell
11,290
-194
-2% -$21.6K ﹤0.01% 2132
2019
Q3
$1.14M Sell
11,484
-295
-3% -$29.3K ﹤0.01% 2122
2019
Q2
$1.17M Sell
11,779
-19,500
-62% -$1.93M ﹤0.01% 2121
2019
Q1
$3.45M Sell
31,279
-7,365
-19% -$812K 0.01% 1412
2018
Q4
$3.55M Buy
38,644
+6,058
+19% +$557K 0.01% 1280
2018
Q3
$3.59M Buy
32,586
+8,861
+37% +$976K 0.01% 1429
2018
Q2
$2.22M Sell
23,725
-11,555
-33% -$1.08M ﹤0.01% 1696
2018
Q1
$2.93M Buy
35,280
+13,962
+65% +$1.16M 0.01% 1457
2017
Q4
$1.94M Buy
21,318
+7,684
+56% +$700K ﹤0.01% 1711
2017
Q3
$1.04M Sell
13,634
-345
-2% -$26.3K ﹤0.01% 2070
2017
Q2
$1.05M Buy
13,979
+4,113
+42% +$309K ﹤0.01% 1997
2017
Q1
$644K Sell
9,866
-1,992
-17% -$130K ﹤0.01% 2232
2016
Q4
$654K Buy
11,858
+2,325
+24% +$128K ﹤0.01% 2165
2016
Q3
$539K Buy
9,533
+3,470
+57% +$196K ﹤0.01% 2226
2016
Q2
$253K Buy
6,063
+9
+0.1% +$376 ﹤0.01% 2507
2016
Q1
$259K Buy
+6,054
New +$259K ﹤0.01% 2422